Book Chapter (3)
221.
Book Chapter
Characterization of PROPPIN–Phosphoinositide Binding by Stopped-Flow Fluorescence Spectroscopy. In: Phosphoinositides (Ed. Botelho, R. J.). Humana, New York, NY (2021)
222.
Book Chapter
Quantitative mass spectrometry-based proteomics: An overview. In: Quantitative Methods in Proteomics, 2. ed. Ed., pp. 85 - 116 (Eds. Marcus, K.; Eisenacher, M.; Sitek, B.). Humana Pr.; Springer, New York (2021)
223.
Book Chapter
Relative quantification of phosphorylated and glycosylated peptides from the same sample using isobaric chemical labelling with a two-step enrichment strategy. In: Quantitative Methods in Proteomics, 2. ed Ed., pp. 185 - 203 (Eds. Marcus, K.; Eisenacher, M.; Sitek, B.). Humana Pr.; Springer, New York (2021)
Working Paper (2)
224.
Working Paper
N4-hydroxycytidine and inhibitors of dihydroorotate dehydrogenase synergistically suppress SARS-CoV-2 replication. bioRxiv, 450163 (2021)
225.
Working Paper
Transcriptome- and genome-targeted cancer immunotherapy. (2021)
Editorial (1)
226.
Editorial
119 (17-18), e1984706 (2021)
Preface to the special issue: The beauty of chemical reaction kinetics, a Festschrift in honour of Jürgen Troe. Molecular Physics Manuscript (3)
227.
Manuscript
Do inhibitors targeted against mutant oncogenic kinases act via kinase degradation-induced immune activation? (2021)
228.
Manuscript
Proposed mechanism for thrombotic thrombocytopenia induced by adenovirus-based COVID-19 vaccines. (2021), 4 pp.
229.
Manuscript
The immune activation model for targeted inhibitors of mutated oncogenic kinases. (2021)